Thank comments this Good I’ll our technology on business business start strategic partnership you, Thanks strategic its joining and update everybody for an regarding morning. and Han. of expansion overview, providing morning. a regarding drivers, our the update a key us few by an lastly, growth transactions, our pipeline. consumer
XXXX. World has of to year widespread been declared Let to economic since a and it pandemic, COVID-XX which full me overview with the day, led start health a Almost the an Health crisis. Organization a
uncertainty. XXXX As a year of has been a result, extreme
pleased Company’s also consumer I’m of the and record our technology, of ingredients XXXX. teams our financial of delivered fourth need sales innovation margins. quarter a product and partners, the and revenue sales needs million and in clean the quarter product portfolio, jointly investors we the to $XXX for year expanding also that the improved position productive the we sustainably transformed working our business, has in and consecutive where it consumers leadership, meet accelerated industry fourth one the ingredients. our We full the history, in while of collaboration and our support most million also of third total delivered are thankful world’s our In advanced quarter, and for gross to years with resilience, for been and respond the $XX and We of sourced natural, revenue, have our strategic continued much position.
$XX our the in was quarter total year XXXX. to equivalent consumer We million brands fourth delivered of growth to that and in consumer continue see strong revenue
times X delivered we XXXX, revenue, nearly revenue. XXXX For the of year full million $XX consumer in
also Our ingredient quarter well, did year. in both very full portfolio and the
million strong first quarter, expanding of For XX% EBITDA have delivered in ingredient demonstrating growth consistent the XXXX, resulted in with of with XXXX. versus fourth expectation the strategic revenue, growth, transaction adjusted over completion $XX product we revenue the in gross positive year full The we margins combined the set.
we new XXXX, servicing a at debt ingredients scale, equity million During completed delivered financing in and from significant debt successful and benefited X costs. $XXX reductions
below during $XXX and have quarter, at million we than the in debt, to Regarding by made debt third less expect quarter. the are further be now current $XXX we million and improvements
strategic that positive in which We payments as be is fourth of the would turn up on We million, to of EBITDA reflecting update revenue, potential done in were the fourth XXXX, million recognized expect the EBITDA $XX at like We with quarter to product first successful from of the an to million our continued closing mentioned results. the now. to you We the with achieved strategic actively remaining will momentum momentum XXXX. on The of the positive along progress with We I adjusted received of conditions. the transactions. the expectation and thereafter. transactions three the for us larger income part in completion in the XXXX, received in $XX meeting in discuss our for transactions. $XX two strategic of We to transaction, valued remainder the previously transactions working quarter two and million $XX milestone that was XXXX, that be with set first in December closed of our year revenue focus we strategic full quarter
The Amyris March, supply the structure larger The moving of production XXXX total transaction of value continue transactions, has earnings can the confirm, to new the added transactions pipeline toward had ingredients. disclosed a $XXX two will process will million $XXX where the total higher the entering $XXX products royalty upfront the over are payments, we This does and the million. now based than components, on where produce to to we not by communicated from from cash value is well be in payments us value molecules payment, that portfolio, four ingredients. the significant of remainder million, our will expected earn-out end and payments molecules up an combination is attributable value through of new and these This I a of the XX-year manufacturer a in estimated final this million. total over agreement We new development and milestone with partners. the of clearance This HSR partner, this the into of from three of that communicated. the antitrust the earnings value be an $XXX includes to be future upfront of molecules previously significantly with a the from entering previously. as these and aggregate of financial represents to total in supply partner, to we of include benefit this production into agreement operating these previously development remain XX-year commercialization value are closing the these
and During sustainably ingredients. of to platform to event, of our market we what the Mini new the sourced Series investor lab technology XXth December is we scale heart process discussed and clean, proprietary power science do commercialize our At chemistry. the and
investment for as our investors hydrocarbon to engineering in have we markets, for sugars convert market is syrup, platform. creation molecules has ingredients used and technology, in development sustainable, we these for years more demand research, chemistry by drivers the clean the to ingredients capability We active where consumer leading in a value another Amyris technology beauty, costs consumer currently to believe clean, all in the With what’s the consumers, and than fastest We lab-to-market this we to are natural finite recreate the XX are That ability pioneered products. scientific clearest create basic That up is cleaning XX use to making we and to and is what’s the and the development. time and that in personal strains effort By and sugarcane mastered of less. fermenting of in products. ingredients Amyris be planet. renewable way world and XX there sustainable unique genetics the health plant commercial have them care sustainable how breakthroughs,
X transactions commercial active a pipeline XX As this of and year. to result new our development to to activity, ingredients add expect we current
adding at a now faster accelerate are rate We ingredients growth. to our long-term
including continue on markets, target and We and fragrances. clean end health beauty, and be to flavor wellness focused
also market. We have one pipeline be we expect to ingredients that in than applicable the more to in
We markets the various category. those have classified in end
about months plant took pilot today, strain we XX from commercial year. first than less to a ingredient average run, Our and
of development Our by XX%. product dropped cost has
reduced time-to-market Our by has XX%.
transactions. a to X market XXXX expand ingredients we revenue development of target at X, ahead our collaborators. number number the with the new proven other of of very growth ingredients R&D and are gained productive years, and that as are is this in and in past in have continued revenue by the the recent to process next profile. lab-to-market development before sector more they gross the The evident process partners the to the while of years versus strategic commercialized, ever have new functions with our portfolio, it recurring around them, our to expected the The we’ve opportunities added and recurring development the of from processes year, from to latest, and ingredients pipeline. margin believe from are strategic X pipeline been in to few to We power ingredients in-market our commercial of companies X a XX development than product pathway being delivering come insights scale, X relates and all Our
as more Our the modern-day It’s biological that synthetic momentum great societal technology we addressing the biology technology. example we our of The for We the network continuous almost have in as path scale, engine an tremendous believe the problems. path, presents effect a strongly become we gains the creation. clearest value for platform we generate only increasingly and more value more impact engineering. efficient from of molecules value the
for enabling truly We are agenda our partners. ESG the
value-add ingredients February event, is through of is Series such squalene are are we the our molecules our at These and our we as sugarcane foundation synergies Amyris have a clean connection discussed our beauty This science During portfolio. we the in X building product hero develop and consumer consumer Mini the undervalued. the ingredient The brands. brands. our between Investor the ingredients misunderstood our portfolio. oftentimes and consumer unique block A for formulations or science, product that from
as are largest clean We beauty our market Biossance well care family clean the also the positioned segment. brand, Pipette, our of beauty is Skincare portion as with global the brand. beauty as and with and fastest-growing skincare well baby
year hair clean are large JVN fast-growing other four -- address will including color we We are and Rose heading cosmetics segments, with adding with that brands new Inc. this care
specialty acne skin care two in that adding Brazil. Amazon care brands, also is morning, a luxury for clean We skin Brazil, treatments; luxury amazing care including in other of brand and region Costa with the Yesterday unique we are announced from Costa a that the ingredients formulations Terasana is and skin very natural This Brazil. acquisition involve the skin market brand.
doubling objective science and exceeding ESG giveback In fermentation the will XXXX, consumer squalene across Overall, Our our than business stronger performance be XXXX, the from. or the using consumer the ingredients with the these of some excellent publication. make tripled in and ingredients consumer support eventually of just our is formulations growth. while with not foundation This delivered creating improve to this business target our our Amazon in to sourced another business mechanisms direct-to-consumer annually. to communities reality, as where planned much originate our story we brand using
more the much again business once double expect consumer than XXXX. We in to
to this drivers growth. We are key executing deliver four year’s on
brands. new First,
I consumers you, the and expanding to brands health are portfolio demanding of four brands performing valuation this them the brands categories. is and for sustainable conditioner standpoint. with growth, hair a become The our scalp year, category tell market care and and benefit better of eventually from significant each formulations much at We well-positioned our respective most by new They market leaders care. also the being clean, than prestige like new least each billion-dollar outstanding shampoos, fueled are sustainable what’s today. products, their hair of experiencing cleanest in in by have the can
XXs, color this the move be We to timed market perfectly a with we Rose clean roaring and real momentum. to to from expect positioned the color later cosmetics we benefit this best-performing as experience expect cosmetics into Inc. year and revival consumer
formulations and exclusive ingredients. Secondly,
you a It’s with the treatment single and are regimen our over a focus We four a is very ever. a excited acne the confident of is afters healthier and expected and product products. not really of single about acne all the more clear single removes clinical where and media the or than looking different channels. product less. acne selling This formulation. breakthrough weeks in The a to social that for compelling acne leaving idea is like like We nourishes before for in skin, your to XX% problem product eliminate data so several on
We are on private other this to reach that formulation billion and with market quick on gains a to brand focus brands maximum $XX limiting X Terasana work we label as market. acne will X in to ensure the we basis the share
potential these market. for the has believe that we in a formulations pipeline, best opportunities of the be collagen breakthrough in several production exclusive have We the including enhancer to the
conditions a all like skin be Terasana focused in melanoma, red We our sustainable like focusing spots exemia ground make four and the way, aging. irritations brand, the as brand to want better will acne, treatments we on
selling Thirdly, in of footage space square doors significant selling and retail. expansion
revenue primary do and of consumer back believe will we business, they in so. when do well. Our direct-to-consumer is source safe We to it’s go our feel consumers stores this
is focus reaching the where Our they consumer are.
incredible stores to The CVS has clean appetite of Fourthly, pace China an us is for than count X,XXX retail. faster of in this imagined. at our luxury Biossance and in over more This includes locations any significant a selling in by year beauty. and significantly and than expansion expansion expanding our Target space have are number Chinese beauty for international. tripling We could Pipette. consumer shifting and the stores Sephora total store for
We focused our this the consumer making care capturing and they ensuring while planet healthier. best have on are skin
We experiencing the China squalene of ingredients our for the are business. in already this markets is one world. fastest-growing in
the brands the to Japan, and next transition take to happen biggest consumer years. lead from this squalene to and to want clean. X current our We X benefit consumer market, from Chinese will lead over expected our We this the
several In addition to countries. European our launching we China, are business direct-to-consumer in
Let summarize. me
future clear. Our is
the are up monetize strategic the giving first our sector Firstly, value. to to is golden way transactions, through we company the goose. fully without self-funding our an innovative become manufacturing in molecules This
manufacturing the We in have the up platform synthetic world, biology we engineered and and of bottleneck, is scaling the industry which effective most highly control chemistry.
the to from production adding X carbon this new leading world’s significant are on one meat XX ingredients zero pipeline we our Secondly, to new a This to producers year. includes development partnership focus with protein of fermentation.
announce contracting phase partnership, the We you. and we’ll we second are this look when partnership in to close quarter. during the new to expect will of This very familiar
funding Our partner the is development molecules. of
We targets. four have early
scale-up development, the produce long do will term. We and
will participate in development Our leaders much in be we chemistry how we technology. in fragrances, the to will big of is responsible for expect themselves and is partner the growing became consumers how and do clean very They fund and the markets continue This where not we commercialization. flavors downstream.
need Our for protein there’s source. here a believe sustainable We simple. plant-based most the as fermentation-based mission is protein,
we partnering to bringing and supply And zero that what exactly the carbon. biology we meat of by with leading out to that carbon is world’s also can the meat, synthetic make need eat producers We and system. the the take consumers chain do understands market, how of and continue production to will one believe meat
Thirdly, we to new revenue growth. are the are lead Last continuing sector X delivered annually. X. commercializing Fourthly, we year, to in we ingredients X
million of $XXX and $XXX range revenue this around year. million the We to deliver underlying expect in total revenue
best-performing becoming a focus beauty. in one built the with of We have leader brand clean the on portfolios
add through well to where over is, by we on consumers wellness in our this Our of growth fill needs X monthly our delivering growing our brands million consumer performance believe and is can scale key and the direct-to-consumer we our metrics platform key beauty on point that are as reach top-tier categories brand way fifth specific we are health, to And we a properties. markets. traffic
clear Eduardo? over We to the we’re bottom execution, call With results have turn to Eduardo. path, focused we’re delivering a that, will and the I line. on
